# Personalized Vaccine for TNBC Immunotherapy

> **NCT06195618** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Universidad Nacional de Colombia** · enrollment: 8 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **BIOLOGICAL:** Peptide (neoantigen) pulsed autologous Dendritic cell

## Key facts

- **NCT ID:** NCT06195618
- **Lead sponsor:** Universidad Nacional de Colombia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06195618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06195618, "Personalized Vaccine for TNBC Immunotherapy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06195618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*